Condition
Depressive Episode
ClinicalTrials.gov condition label
Explore related research
Search across original and mapped recordsSearch results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 23 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
23 shownImproving Treatment for Depression in General Practice Using a Step-by-Step Care Plan.NCT07263321 · 2025-12-01
RECRUITINGComparing the Efficacy of fMRI-Guided vs. Standard iTBS in Treating DepressionNCT06152705 · 2024-09-16
RECRUITINGComparing Outcomes of Theta Burst Stimulation in Depression Using Advanced PET ImagingNCT07620288 · 2026-08-01
NOT_YET_RECRUITINGKetosis Impact on Signs & Symptoms of Schizophrenia and Bipolar disorderSNCT06426134 · 2024-12-01
COMPLETEDStudy of Virtual Reality-based Medical Device for Patients with Depressive DisorderNCT05701345 · 2023-03-09
COMPLETEDStudy to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)NCT05686408 · 2023-03-02
COMPLETEDPrediction and Validation of Unipolar Depression With Psychosocial-somatic Markers in a Naturalistic Cohort Recruited in an Outpatient SettingNCT05547711 · 2022-10-15
NOT_YET_RECRUITINGSleep Signal Analysis for Current Major Depressive Episode (SAMDE)NCT05708222 · 2022-09-01
COMPLETEDDigital Therapeutic for Adolescent Depressive Symptoms in Cardiology and GastroenterologyNCT05461599 · 2022-08-25
TERMINATEDRisk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on HealthNCT05206734 · 2022-01-05
COMPLETEDThe Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataNCT04239521 · 2020-10-01
COMPLETEDEfficacy of Deep Anaesthesia With Isoflurane as a Fast-response Antidepressant AgentNCT04171193 · 2019-12-01
UNKNOWNPre-mapping Networks for Brain Stimulation 2NCT05260086 · 2019-04-15
COMPLETEDTheta-Burst Stimulation in Major Depressive Episodes With Mixed Characteristics.NCT04123301 · 2019-03-08
UNKNOWNSingle Session of tACS in a Depressive EpisodeNCT03449979 · 2018-09-19
COMPLETEDResting-state Functional Connectivity Throughout a Course of iTBS in Major DepressionNCT03944213 · 2018-07-23
UNKNOWNA Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 DepressionNCT03543410 · 2018-06-26
COMPLETEDCombinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive DisorderNCT03537547 · 2018-05-04
TERMINATEDAdaptive Design Study of NEST sTMS in Subjects With Major Depressive DisorderNCT03288714 · 2017-11-27
COMPLETEDStimulation of Parieto-hippocampal Connectivity in Patients With Major Depressive DisorderNCT04081519 · 2016-08-02
COMPLETEDConfirmation Bias Towards Treatments of Depressive Disorders in Social TaggingNCT03899168 · 2014-11-14
COMPLETEDPharmacogenetic Implementation Trial in Veterans With Treatment Refractory DepressionNCT04469322 · 2014-09-30
COMPLETEDIncreasing the Efficiency of Depression-screening Using Patient-targeted FeedbackNCT01879111 · 2011-10-01
COMPLETEDCommon interventions
PlaceboDRUG2repetitive Transcranial Magnetic StimulationDEVICE2(R)-3-hydroxybutyl (R)-3-hydroxybutyrate)DIETARY_SUPPLEMENT1active rTMS over DLPFCDEVICE1Active Theta Burst Stimulation (TBS)DEVICE1Add-on active rTMS over DLPFCDEVICE1Add-on active rTMS over LPCDEVICE1Add-on sham rTMSDEVICE1Algorithm-Based TreatmentOTHER1Confidence in Prior AttitudesOTHER1drawing bloodDIAGNOSTIC_TEST1Exposure of interest (studies 2 & 3).OTHER1FDA-approved antidepressant or antipsychotic treatmentDRUG1GeneSight Psychotropic testOTHER1intermittent theta burst stimulation (iTBS)DEVICE1IsofluraneDRUG1Maltodextrin, Fructose, Pectin, Sodium alginate, Sodium chlorideOTHER1MEB-001DEVICE1Mental Health DNA Insight Test (Pathway Genomics)DIAGNOSTIC_TEST1Neuronavigated aiTBSDEVICE1No specific interventionOTHER1OMNIFIT DTx-MDDDEVICE1patient-targeted feedbackOTHER1SEP-4199 200 mgDRUG1SEP-4199 400 mgDRUG1
Mapped drugs appearing in these trials
Shared trial participation only; not evidence of efficacy or approval.
Leading sponsors
Momentum Data
2
The Royal Ottawa Mental Health Centre
2
University Hospital, Bonn
2
University of Sao Paulo
2
Aalborg University Hospital
1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
1
Julia Eder
1
Leibniz-Institut für Wissensmedien
1
Limbix Health, Inc.
1
Medibio Limited
1
Omni C&S
1
San Diego Veterans Healthcare System
1
Sumitomo Pharma America, Inc.
1
Tonix Pharmaceuticals, Inc.
1
Universitätsklinikum Hamburg-Eppendorf
1
Trial status mix
COMPLETED14
UNKNOWN3
NOT_YET_RECRUITING2
RECRUITING2
TERMINATED2
Phase mix
NA15
PHASE23
PHASE41
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.